The vascular micromilieu in obstructive sleep apnoea

European Respiratory Journal

Volumn 25, Issue 5, 2005, Pages 780-782

  Schulz, Richard ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ADRENALIN; AMYLOID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD8 ANTIGEN; CELL ADHESION MOLECULE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; NITRIC OXIDE DONOR; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CYTOTOXICITY; EDITORIAL; HEART INFARCTION; HEART PROTECTION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; MICROVASCULARIZATION; OXIDATIVE STRESS; PERONEUS NERVE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REOXYGENATION; RISK FACTOR; SLEEP APNEA SYNDROME; STROKE; SYMPATHETIC TONE; T LYMPHOCYTE; UPPER RESPIRATORY TRACT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; SLEEP APNEA, OBSTRUCTIVE; VASCULAR DISEASES;

EID: 18744371630     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00022905     Document Type: Editorial

References (23)

1. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
2. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
3. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross sectional results of the Sleep Heart Study. Am J Respir Crit Care Med 2001; 163: 19-25.
4. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996; 14: 577-584.
5. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Med 2004; 169: 348-353.
6. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
7. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103: 1763-1768.
8. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
9. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676.
10. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-570.
11. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939.
12. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea - response to CPAP therapy. Thorax 2000; 55: 1046-1051.
13. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep. Sleep 2004; 27: 123-128.
14. von Kanel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardivascular disease - opinions/hypotheses. Chest 2003; 124: 1956-1967.
15. Chin K, Nakamura T, Shimizu K, et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000; 109: 562-567.
16. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316.
17. Tazaki T, Minoguchi K, Yokoe T, et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 170: 1354-1359.
18. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-2464.
19. Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK. Serum amyloid a in obstructive sleep apnea. Circulation 2003; 108: 1451-1454.
20. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood γδ-T cells in sleep apnea. Am J Respir Crit Care Med 2003; 168: 242-249.
21. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002; 33: 1782-1785.
22. Schulz R, Seeger W, Fegbeutel C, et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 2005; 25: 69-74.
23. Dyugovskaya L, Lavie P, Hirsh M, Lavie L. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 2005; 25: 820-828.